SCH-79687 is a synthetic small molecule that functions as a selective histamine H₃ receptor antagonist. Originally described pharmacologically in 2003, it exhibits both in vitro and in vivo H₃-blocking activity and has demonstrated wake-promoting properties, potential anti-obesity effects, and nasal decongestion (particularly when administered alongside an H₁ antagonist) .